Lung Cancer
AI partners with liquid biopsy for ‘robust’ identification of women with ovarian cancer
An artificial intelligence-driven algorithm used a novel liquid biopsy assay to differentiate women with ovarian cancer from healthy patients, according to results presented at American Association for Cancer Research Annual Meeting.
New cancer diagnoses projected to reach 35 million worldwide in 2050
New global cancer diagnoses could reach 35 million by the year 2050, according to a report from the American Cancer Society published in CA: A Cancer Journal for Clinicians.
Research shows complexity of shared decision-making about lung cancer screening
Patients with multimorbidity and limited life expectancy are often unaware of the risks of lung cancer screening, and clinicians might be hesitant to discuss it, according to a pair of studies published in the Annals of Family Medicine.
Krazati slows disease progression in certain patients with lung cancer
Adagrasib monotherapy improved PFS and overall response rate among adults with pretreated locally advanced or metastatic non-small cell lung cancer harboring a KRASG12C
California doctor with lung cancer receives first-of-its-kind lung-liver transplant
Surgeons at Northwestern Medicine Canning Thoracic Institute have performed what is believed to be the first-ever combined lung-liver transplant for a patient with advanced lung cancer, according to medical staff at Northwestern Medicine.
Keytruda-Lynparza combination misses survival targets in phase 3 lung cancer trial
The combination of pembrolizumab and maintenance olaparib failed to significantly improve survival outcomes among adults with metastatic nonsquamous non-small cell lung cancer, according to the agent’s manufacturer.
Nearly half of patients with positive lung cancer screening findings delay follow-up care
Patients with positive lung cancer screening findings frequently delay their first follow-up visit, according to results published in Annals of the American Thoracic Society.
Radiation oncologist calls on field to ‘advocate and educate’ as numbers fall
Arya Amini, MD, still remembers sitting on the steps outside of his dean’s office at University of California, Irvine, more than a decade ago, prepared to race inside in case he did not get matched with a radiation oncology residency.
FDA approves Rybrevant for treatment of non-small cell lung cancer
The FDA on Friday approved Rybrevant in combination with chemotherapy as the first first-line treatment of locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations, Johnson & Johnson announced.
Esteemed Peer Perspective Board helps chart course for Healio’s Women in Oncology
Women in Oncology, a first-of-its kind effort from Healio, will inform, inspire, engage and empower female professionals with guidance from those who have exceled in their professional careers, mentored younger doctors, and led full and rewarding personal lives.